adalimumab vs cyclosporine

According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.

Side-by-side comparison of adalimumab and cyclosporine. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

minor Known Drug Interaction

Upon initiation or discontinuation of IDACIO in patients being treated with CYP450 substrates with a narrow therapeutic index, monitoring of the effect (e.g., warfarin) or drug concentration (e.g., cyclosporine or theophylline) is recommended and the individual dose of the drug product may be adjusted as needed.

Drug Class
adalimumab TNF-Alpha Inhibitor (Biologic)
cyclosporine Calcineurin Inhibitor (Immunosuppressant)
Type
adalimumab Prescription
cyclosporine Prescription
Summary
adalimumab

Idacio is a medicine that blocks a protein called TNF. It is used to treat several diseases, including arthritis and Crohn's disease.

cyclosporine

Vevye eye drops contain cyclosporine. They help treat the signs and symptoms of dry eye disease.

What It Treats
adalimumab

Idacio can help adults with rheumatoid arthritis by reducing joint pain and damage. It can also help children (2 years and older) with juvenile idiopathic arthritis. Idacio treats psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa and uveitis.

cyclosporine

Vevye treats the signs and symptoms of dry eye disease. Dry eye can cause discomfort, stinging, and blurred vision. This medicine can help reduce these symptoms.

How It Works
adalimumab

Idacio works by blocking a protein in your body called tumor necrosis factor (TNF). TNF can cause inflammation and damage in certain diseases. By blocking TNF, Idacio can reduce these symptoms.

cyclosporine

Vevye contains cyclosporine, which is an immunosuppressant. It works by decreasing inflammation in the eyes. This helps your eyes make more tears.

Common Side Effects
adalimumab
  • Infections (like colds or sinus infections)
  • Injection site reactions (redness, itching, pain, or swelling)
  • Headache
  • Rash
cyclosporine
  • Irritation where the drops are applied (8%)
FAERS Reports
adalimumab
  • Pain 49,062
  • Arthralgia 48,039
  • Injection Site Pain 47,251
  • Fatigue 39,111
  • Rheumatoid Arthritis 35,573
cyclosporine
  • Eye Irritation 7,786
  • Pyrexia 4,064
  • Eye Pain 3,808
  • Nausea 3,623
  • Diarrhoea 3,562
Serious Warnings
adalimumab

Idacio can increase your risk of serious infections that could lead to hospitalization or death. Tell your doctor if you have any infections before starting Idacio. Idacio may also increase your risk of certain cancers, including lymphoma. Children and teens taking TNF blockers like Idacio have developed rare, aggressive cancers.

cyclosporine

To avoid eye injury or contamination, do not touch the bottle tip to your eye or any other surface. Do not use Vevye while wearing contact lenses. If you wear contacts, remove them before using the drops. You can put them back in 15 minutes after using Vevye.

Pregnancy
adalimumab

Tell your doctor if you are pregnant or plan to become pregnant. Idacio can cross the placenta and may affect your baby's immune system. Talk to your doctor about vaccines for your baby if you took Idacio during pregnancy.

cyclosporine

It is not known if Vevye will harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. Cyclosporine can pass into breast milk after being taken orally, but it is unknown if it passes into breast milk from eye drops. Talk to your doctor if you are breastfeeding.

Also Compare, Nearby Drugs

How to Read This adalimumab vs cyclosporine Comparison

adalimumab is classified in the TNF-Alpha Inhibitor (Biologic) drug class, while cyclosporine sits within the Calcineurin Inhibitor (Immunosuppressant) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, adalimumab has 219,036 submissions while cyclosporine has 22,843. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to adalimumab can change how your liver breaks down other medicines, which can cause the amount of cyclosporine in your blood to change.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for adalimumab or cyclosporine.

Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.